New advances in synthetic biology enable rapid, accurate, and reproducible writing of DNA and mRNA for wide-ranging biological applications that replace the need to outsource to a vendor ...

3 investigational HIV-1 trimer mRNA vaccines induced mild- to moderate-adverse effects in a phase 1, randomized trial. HealthDay News — Urticaria is seen in association with experimental HIV-1 mRNA ...

How to contact Nature Biotechnology executives were elated. Trump had, just five years earlier, propelled mRNA medicines into the spotlight through his signature effort to fast-track the ...

Scroll down for a transcription of this episode. We explore how making art can ground us in the present and be a space of healing, connection, and joy. Summary: We explore how creative expression can ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. By Kate Zernike To ...

That’s why a bill introduced last month at the Minnesota Legislature, HF 3219 — which attempts to label mRNA technology as a “biological weapon” — isn’t just misguided. It’s dangerous.

(There are no approved mRNA-based flu shots.) The trial, funded by Moderna, included more than 8,000 adults ages 50 and older who were enrolled in October and November 2023. For people ages 50 to ...

Provenance researcher Rudi Ekkart speaks about Camille Pissarro’s Girl Lying on the Grass, which was sold under duress during the Second World War. Photo by Sina Schuldt/picture alliance via ...

Eye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University, Hangzhou, Zhejiang 310018, China National Clinical Research Center for ...

Article Summary Tickets are now on sale for Disney's live-action Lilo & Stitch, with a new movie clip unveiled to celebrate. Five brand new posters have been released alongside the new footage ...

Ver­tex paused an ear­ly-stage tri­al of its in­haled treat­ment for cys­tic fi­bro­sis that came from a part­ner­ship with Mod­er­na.

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins ...